ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: ASCO awards career development grants.

May 21, 2004

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

August 30, 2013

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

Funding opportunties listed.

December 3, 2004

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014